These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 22994057

  • 1. [The correction of dysipidemia in patients presenting with coronary heart disease in the course of the spa and resort-based treatment].
    Leonchuk AL, Merkulova GA.
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (4):8-9. PubMed ID: 22994057
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE, Hammerash WJ.
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [Abstract] [Full Text] [Related]

  • 6. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH.
    Circulation; 2007 Mar 20; 115(11):1363-70. PubMed ID: 17353444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV, Frick KD, Wade A, Simko R, Burge R.
    Clin Ther; 2009 Apr 20; 31(4):862-79. PubMed ID: 19446159
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May 20; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 11. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug 20; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S, Hilleman D.
    Pharmacotherapy; 2008 May 20; 28(5):570-5. PubMed ID: 18447655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M, Ginsberg HN, Schaefer EJ.
    Am J Cardiol; 2008 Apr 01; 101(7):1003-8. PubMed ID: 18359322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP, Potter D, Ming EE.
    J Clin Lipidol; 2012 Apr 01; 6(4):325-30. PubMed ID: 22836069
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [An analysis of cases of exacerbation of coronary insufficiency in patients during Kislovodsk health resort treatment (according to data of a health resort hospital)].
    Vertkin LIa, Trofimova VV.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1967 Apr 01; 32(3):197-200. PubMed ID: 5620373
    [No Abstract] [Full Text] [Related]

  • 20. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW, L-TAP 2 Investigators.
    Am Heart J; 2009 Nov 01; 158(5):860-6. PubMed ID: 19853709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.